Journal of International Society of Preventive and Community Dentistry

REVIEW ARTICLE
Year
: 2022  |  Volume : 12  |  Issue : 5  |  Page : 488--499

Evaluation of current evidence on the use of oral antiseptics against SARS-CoV-2: A narrative review


Victor Chumpitaz-Cerrate, Lesly Chávez-Rimache, Eliberto Ruiz-Ramirez, César Franco-Quino, Carlos Erazo-Paredes 
 Group “Investigación en Ciencias Básicas Estomatológicas ICBEST,” Universidad Nacional Mayor de San Marcos, Lima, Perú

Correspondence Address:
Dr. Victor Chumpitaz-Cerrate
Germán Amézaga Nro. 375, Lima
Perú

Aims and Objectives: The detection of SARS-COV-2 in the oral cavity has generated endless claims about the efficacy of using oral mouthwashes to reduce viral load. This review aims to assess the current evidence on the use of oral antiseptics against SARS-CoV-2 and to assess the certainty of the evidence according to the GRADE system. The question this study focussed on was what is the efficacy of oral antiseptics against SARS-CoV-2? Materials and Methods: A bibliographic search was performed in Medline databases through PubMed, Science Direct, and Google Scholar (until February 2022), using search terms related to COVID-19 and oral antiseptics. Two independent researchers extracted the information from the articles included in an excel form. The identification and selection of the studies was carried out from August 2021 to February 2022. Results: It was found that oral antiseptics can have a potential beneficial effect on COVID-19, mainly in reducing viral load. However, these potential benefits are mainly based on in-vitro studies or clinical studies with various methodological limitations. At present, the certainty of the evidence is very low due to inconsistency (heterogeneity), moderate-to-high risk of bias, and imprecision of the results. Conclusion: The certainty of the current evidence on the efficacy of oral antiseptics against SARS-CoV-2 is very low, mainly due to the methodological limitations of the studies. Therefore, for evidence-based decision-making about this intervention, clinical studies with greater methodological rigor are required. Oral antiseptics could present potential benefits in patients with COVID-19 mainly by reducing viral load. However, a careful and conscious evaluation of the evidence is required for decision-making in clinical practice.


How to cite this article:
Chumpitaz-Cerrate V, Chávez-Rimache L, Ruiz-Ramirez E, Franco-Quino C, Erazo-Paredes C. Evaluation of current evidence on the use of oral antiseptics against SARS-CoV-2: A narrative review.J Int Soc Prevent Communit Dent 2022;12:488-499


How to cite this URL:
Chumpitaz-Cerrate V, Chávez-Rimache L, Ruiz-Ramirez E, Franco-Quino C, Erazo-Paredes C. Evaluation of current evidence on the use of oral antiseptics against SARS-CoV-2: A narrative review. J Int Soc Prevent Communit Dent [serial online] 2022 [cited 2022 Dec 2 ];12:488-499
Available from: https://www.jispcd.org/article.asp?issn=2231-0762;year=2022;volume=12;issue=5;spage=488;epage=499;aulast=Chumpitaz-Cerrate;type=0